Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma

Pathology and Oncology Research

Volumn 16, Issue 1, 2010, Pages 47-53

  Zhang, Che ^a   Tu, Ziliang ^a   Du, Shiming ^a   Wang, Yong ^a   Wang, Qibin ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Clinicopathology; EMMPRIN; Intrahepatic cholangiocarcinoma; MMP 2; Prognosis

Indexed keywords

CD147 ANTIGEN; GELATINASE A;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD147; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77949659392     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9186-5     Document Type: Article

References (28)

1. K Itatsu Y Zen J Yamaguchi 2008 Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts Hum Pathol 39 710 719 10.1016/j.humpath.2007.09.016 1:CAS:528:DC%2BD1cXlvVCntbY%3D 18329694
2. K Itatsu Y Zen S Ohira 2007 Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis Liver Int 27 1174 1184 17919228
3. BK Park YH Paik JY Park, et al. 2006 The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma Am J Clin Oncol 29 138 142 10.1097/01.coc.0000204402.29830.08 1:CAS:528:DC%2BD28XktlSms7w%3D 16601431 (Pubitemid 44270951)
4. XH Fu ZH Tang M Zong GS Yang XP Yao MC Wu 2004 Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients Hepatobiliary Pancreat Dis Int 3 279 283 15138126
5. H Malhi GJ Gores 2006 Cholangiocarcinoma: modern advances in understanding a deadly old disease J Hepatol 45 856 867 10.1016/j.jhep.2006.09. 001 1:CAS:528:DC%2BD28XhtFeqtLvM 17030071 (Pubitemid 44646688)
6. A Nanashima Y Sumida T Abo M Oikawa G Murakami H Takeshita H Fukuoka S Hidaka T Nagayasu I Sakamoto T Sawai 2008 Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma J Surg Oncol 98 535 539 10.1002/jso.21142 18814285
7. K Nabeshima J Suzumiya M Nagano K Ohshima BP Toole K Tamura, et al. 2004 Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas J Pathol 202 341 351 10.1002/path.1518 1:CAS:528:DC%2BD2cXislejsbo%3D 14991900 (Pubitemid 38325244)
8. B Davidson I Goldberg A Berner GB Kristensen R Reich 2003 EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma Clin Exp Metastasis 20 161 169 10.1023/A:1022696012668 1:CAS:528:DC%2BD3sXhslOkt74%3D 12705637 (Pubitemid 36403281)
9. W-C Tsai Y-C Chao L-F Sheu Y-F Lin S Nieh A Chen C-P Yu J-S Jin 2007 EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people APMIS 115 929 938 10.1111/j.1600-0463.2007.apm-858.x 17696949 (Pubitemid 47256286)
10. S Riethdorf N Reimers V Assmann JW Kornfeld L Terracciano G Sauter, et al. 2006 High incidence of EMMPRIN expression in human tumors Int J Cancer 119 1800 1810 10.1002/ijc.22062 1:CAS:528:DC%2BD28Xps1Sns7s%3D 16721788 (Pubitemid 44356836)
11. H Guo R Li S Zucker BP Toole 2000 EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface Cancer Res 60 888 891 1:CAS:528:DC%2BD3cXhs1Shsr8%3D 10706100
12. K Nabeshima H Iwasaki K Koga H Hojo J Suzumiya M Kikuchi 2006 Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression Pathol Int 56 359 367 10.1111/j.1440-1827.2006.01972.x 1:CAS:528:DC%2BD28Xos1Grsbc%3D 16792544 (Pubitemid 43886799)
13. M-F Cheng W Tzao W-C Tsai W-H Lee A Chen H Chiang L-F Sheu J-S Jin 2006 Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters Dis Esophagus 19 482 486 10.1111/j.1442-2050.2006.00613.x 17069593 (Pubitemid 44644686)
14. PJ Cozzi J Wang W Delprado AC Perkins BJ Allen PJ Russell Y Li 2005 MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer Clin Exp Metastasis 22 565 573 10.1007/s10585-005-5376-z 1:CAS:528: DC%2BD28XjsVyiu7c%3D 16475027 (Pubitemid 43234641)
15. Y Tang P Kesavan T Marian 2004 Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expressio and matrix metalloproteinase-dependent generation of soluble EMMPRIN molecular Cancer Res 2 73 80 1:CAS:528:DC%2BD2cXisVGqtLY%3D
16. AA Romani P Soliani S Desenzani AF Borghetti P Crafa 2006 The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma BMC Cancer 6 255 10.1186/1471-2407-6-255 17067385
17. Q Li J-M Wang C Liu B-L Xiao J-X Lu S-Q Zou 2008 Correlation of aPKC-ι and E-cadherin expression with invasion and prognosis of cholangiocarcinoma Hepatobiliary Pancreat Dis Int 7 70 75 18234642
18. N Reimers K Zafrakas V Assmann C Egen L Riethdorf S Riethdorf, et al. 2004 Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells Clin Cancer Res 10 3422 3428 10.1158/1078-0432.CCR-03-0610 1:CAS:528:DC%2BD2cXkt1GhsLc%3D 15161697 (Pubitemid 38685448)
19. Y Noguchi T Sato M Hiratam T Hara K Ohama A Ito 2003 Identification and characterization of extracellular matrix metalloproteinase inducer in human endometrium during the menstrual cycle in vivo and in vitro J Clin Endocrinol Metab 88 6063 6072 10.1210/jc.2003-030457 1:CAS:528:DC%2BD3sXhtVSgsrnI 14671212 (Pubitemid 38033094)
20. W Li N Alfaidy JRG Challis 2006 Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor J Clin Endocrinol Metab 89 2897 2904 10.1210/jc.2003-032048
21. NA Haseneen GG Vaday S Zucker HD Foda 2003 Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN Am J Physiol Lung Cell Mol Physiol 284 L541 L547 1:CAS:528:DC%2BD3sXisFensLw%3D 12456388
22. J-S Jin D-S Hsieh Y-F Lin J-Y Wang L-F Sheu W-H Lee 2006 Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters Int J Urol 13 573 580 10.1111/j.1442-2042.2006. 01353.x 1:CAS:528:DC%2BD28XmslSitro%3D 16771728 (Pubitemid 43760423)
23. QQ Li WJ Wang JD Xu XX Cao Q Chen JM Yang 2007 Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells Cancer Sci 98 1767 1774 10.1111/j.1349-7006.2007.00593.x 1:CAS:528:DC%2BD2sXht1eis7nI 17725804 (Pubitemid 47487914)
24. S Riethdorf N Reimers V Assmann JW Kornfeld L Terracciano G Sauter 2006 High incidence of EMMPRIN expression in human tumors Int J Cancer 119 1800 1810 10.1002/ijc.22062 1:CAS:528:DC%2BD28Xps1Sns7s%3D 16721788 (Pubitemid 44356836)
25. Y Tang MT Nakada P Kesavan F McCabe H Millar P Rafferty 2005 Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases Cancer Res 65 3193 3199 1:CAS:528:DC%2BD2MXjt1yktb4%3D 15833850
26. Y Ishibashi T Matsumoto M Niwa Y Suzuki N Omura N Hanyu, et al. 2004 CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma Cancer 101 1994 2000 10.1002/cncr.20593 1:CAS:528:DC%2BD2cXhtVShtb7M 15372476 (Pubitemid 39425374)
27. B Davidson V Givant-Horwitz P Lazarovici B Risberg JM Nesland CG Trope E Schaefer R Reich 2003 Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma Clin Exp Metastas 20 621 631 10.1023/A:1027347932543 1:CAS:528:DC%2BD3sXos1amtrY%3D (Pubitemid 37463899)
28. S Sillanpää M Anttila K Suhonen K Hämäläinen T Turpeenniemi-Hujanen U Puistola, et al. 2007 Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer Tumour Biol 28 280 289 10.1159/000110426 17962725 (Pubitemid 350165834)